Current therapy of major fungal diseases of the lung
- PMID: 1955703
Current therapy of major fungal diseases of the lung
Abstract
The treatment of the major systemic fungi encountered in the United States--Histoplasma capsulatum, Blastomyces dermatitides, and Coccidioides immitis--depends on an understanding of the natural history of disease. Clinical manifestations of these infections can range from an asymptomatic disease that requires no therapy to an illness that is incurable and requires long-term suppression with antifungal agents to produce a balanced host-to-parasite relationship. This article discusses the natural history of disease caused by H. capsulatum, B. dermatitides, and C. immitis and various clinical situations that require antifungal chemotherapy.
Similar articles
-
Community-acquired fungal pneumonias.Semin Respir Infect. 1989 Mar;4(1):56-63. Semin Respir Infect. 1989. PMID: 2652235 Review.
-
Community-acquired fungal pneumonia in children.Semin Respir Infect. 1996 Sep;11(3):196-203. Semin Respir Infect. 1996. PMID: 8883177 Review.
-
Fungal infection of the lung. The big 3--histoplasmosis, blastomycosis, coccidioidomycosis.Postgrad Med. 1983 Jun;73(6):242-51. doi: 10.1080/00325481.1983.11697878. Postgrad Med. 1983. PMID: 6856531
-
Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.Mycopathologia. 1999;146(2):53-65. doi: 10.1023/a:1007081707287. Mycopathologia. 1999. PMID: 10822504 Review.
-
[Therapy of pulmonary mycoses].Dtsch Med Wochenschr. 1992 Nov 6;117(45):1725-9. doi: 10.1055/s-2007-1024318. Dtsch Med Wochenschr. 1992. PMID: 1330477 Review. German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical